Viralgen relies on a proprietary manufacturing platform, advanced applications of data, and broad experience to accelerate production
Gene therapies have the potential to change lives, but regulatory processes can be complex and challenging. Successful collaboration between biotech companies and regulatory agencies is essential to ensure that these innovative treatments reach patients efficiently and safely. In this article, experts discuss the key strategies for working with regulators to streamline approvals, address safety concerns, and ultimately make gene therapies accessible to more patients worldwide.
